Immunome Inc. (IMNM) is a publicly traded company in the Unknown sector. Across all available filings, 16 corporate insiders have executed 53 transactions totaling $16.8M, demonstrating a bearish sentiment with -$432.1K in net insider flow. The most recent transaction on Dec 30, 2025 involved a purchase of 4,729 shares valued at $100.0K.
No significant insider buying has been recorded for IMNM in the recent period.
No significant insider selling has been recorded for IMNM in the recent period.
Based on recent SEC filings, insider sentiment for IMNM is bearish with an Insider Alignment Score of 49/100 and a net flow of -$432.1K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Immunome Inc. (IMNM) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 16 insiders are actively trading IMNM stock, having executed 53 transactions in the past 90 days. The most active insider is Isaac Barchas (Executive), who has made 2 transactions totaling $8.3M.
Get notified when executives and directors at IMNM file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 30, 2025 | B. Siegall Clay | Executive | Purchase | 4,729 | $21.15 | $100.0K | |
| Dec 22, 2025 | Barchas Isaac | Executive | Sale | 11,251 | $22.34 | $251.3K | |
| Dec 22, 2025 | Barchas Isaac | Executive | Sale | 371,949 | $21.72 | $8.1M | Large |
| Dec 19, 2025 | Tsai Philip | Executive | Purchase | 10,000 | $20.49 | $204.9K | |
| Dec 19, 2025 | B. Siegall Clay | Executive | Purchase | 7,278 | $20.48 | $149.1K | |
| Dec 19, 2025 | B. Siegall Clay | Executive | Gift | 200,000 | $N/A | $0 | |
| Dec 19, 2025 | Higgins Jack | Executive | Gift | 1,000 | $N/A | $0 | |
| Dec 19, 2025 | Higgins Jack | Executive | Gift | 1,000 | $N/A | $0 | |
| Dec 19, 2025 | Higgins Jack | Executive | Gift | 1,000 | $N/A | $0 | |
| Dec 19, 2025 | Higgins Jack | Executive | Gift | 1,000 | $N/A | $0 | |
| Dec 19, 2025 | Higgins Jack | Executive | Gift | 1,000 | $N/A | $0 | |
| Dec 19, 2025 | Higgins Jack | Executive | Gift | 1,000 | $N/A | $0 | |
| Dec 18, 2025 | B. Siegall Clay | Executive | Purchase | 46,511 | $21.50 | $1000.0K | Large |
| Sep 10, 2025 | Higgins Jack | Executive | Option Exercise | 22,000 | $1.35 | $29.7K | |
| Sep 19, 2024 | Rosett Max | Executive | Option Exercise | 42,000 | $1.05 | $44.1K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 4 | $8.6M | 46.2% |
Purchase(P) | 25 | $8.2M | 43.9% |
Award(A) | 6 | $1.7M | 9.2% |
Exercise(M) | 4 | $126.8K | 0.7% |
Gift(G) | 8 | $0 | 0.0% |
Conversion(C) | 6 | $0 | 0.0% |
Insider activity at Immunome Inc. shows mixed signals across all time. While $8.2M in purchases indicates some executive confidence,$8.6M in sales balances the picture, resulting in a modest net flow of -$432.1K.16 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Isaac Barchas, has transacted $8.3M during this period.